Mohamed Shebl AbdelBaki MD

Pediatric Hematology & Oncology•St. Louis, MO

Pediatric Neuro-Oncology

Director, Neuro-Oncology Program, St. Louis Children's Hospital and Associate Professor of Pediatrics, Washington University School of Medicine

Join to view full profile

1 Childrens Pl# DivSt. Louis, MO 63110
Phone+1 314-454-6018
Fax+1 844-621-4392

Dr. AbdelBaki is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. AbdelBaki's full profile Already have an account?

Summary

Dr. Mohamed Shebl Abdelbaki is the Director of the Pediatric Neuro-Oncology Program and the Clinical Research Office (CRO) for the Pediatric Hematology, Oncology and Bone Marrow Transplant Division at St. Louis Children's Hospital, and an Associate Professor of Pediatrics at Washington University School of Medicine in St. Louis – Missouri (USA). He is a member of the Central Nervous System (CNS) Committee at the Children’s Oncology Group (COG), and the study chair of the CNS Germinoma trial (ACNS2321) as well as a study committee member for the CNS non-germinomatous germ cell tumor clinical trial (ACNS2021). Additionally, he is the institutional Principal Investigator for both the COllaborative Network for NEuro-oncology Clinical Trials (CONNECT) consortium as well as the Pediatric Neuro-Oncology consortium (PNOC) – where he leads several clinical trials in pediatric brain tumors and also serves as a member of the scientific committee and the Chair of the Germ Cell Tumor Working Group.

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
Albany Medical CenterResidency, Pediatrics, 2006 - 2009
Cairo University School of MedicineClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State Medical License 2020 - 2027
OH State Medical License 2015 - 2021
PA State Medical License 2011 - 2014
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Partners in Care, Partners in Hope Family Centered Care Award Nationwide Children's Hospital, 2016

Clinical Trials

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells Start of enrollment: 2025 Mar 04
RECRUITING
PHASE1
Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors Start of enrollment: 2021 Dec 03
TERMINATED
PHASE1
Roles: Principal Investigator
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma Start of enrollment: 2018 Sep 24
TERMINATED
PHASE1, PHASE2
Roles: Contact

Publications & Presentations

PubMed

Infant Embryonal CNS Tumors: Molecular Insights and Treatment Considerations for Contemporary Pediatric Neuro-Oncology.
Sudarshawn Damodharan, Mariah Wright-Nadkarni, Mohamed S Abdelbaki, Girish Dhall
Pediatric Blood & Cancer. 2026-08-20
A multi-institutional report of children with atypical teratoid rhabdoid tumor treated with intensive multimodal therapy.
Ashley S Margol, Lindsey M Hoffman, Rebecca Ronsley, Jane Tran, Jemily Malvar
Neuro-Oncology Practice. 2026-08-01
Central Nervous System Neuroblastoma, FOXR2-Activated: A Pooled Analysis of Published Clinical Outcomes.
Sudarshawn Damodharan, Mohamed S Abdelbaki
Pediatric Blood & Cancer. 2026-07-29